Dextromethorphan and guaifenesin syrup formulation or suspension
US11931413B2 · kind B2 · utility
0Cited by
4References
25Claims
0Family size
Inventors
Key dates
| Filing date | Aug 19, 2022 |
| Grant date | Mar 19, 2024 |
| Priority date | — |
| Expiry date | Aug 19, 2042 |
Classification
- Technology area (CPC H)Electricity
- CPC primaryH01J2235/084
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A stable pharmaceutical formulation or suspension has a pharmaceutical active agent, agave, and a dilutant. The formulation or suspension has viscosity suitable for drinking.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.